R1008- A Randomized Phase II Study Of Adjuvant Concurrent Radiation And Chemotherapy Versus Radiation Alone In Resected High-Risk Malignant Salivary Gland Tumors
Posted Date: May 15, 2019
- Investigator: Trisha Wise-Draper
- Specialties: Cancer, Head and Neck Cancer, Oncology
- Type of Study: Drug
This study will compare the good and bad effects of radiation and chemotherapy with radiation alone on salivary gland cancer to find out which is better at reducing the chance of the cancer returning.
Criteria:
To Be Eligible: Must Have Cancer Of The Salivary Gland That Has Been Removed By Surgery, Age 18 Or Older, Nonpregnant, No Prior Invasive Malignancy In 3 Years.
Keywords:
Head And Neck Cancer, Salivary Gland, Radiation, Rtog 1008, Salivary Gland
For More Information:
Uc Cancer Center
513-584-7698
cancer@uchealth.com